163 reports of this reaction
4.3% of all IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE reports
#2 most reported adverse reaction
DRUG INEFFECTIVE is the #2 most commonly reported adverse reaction for IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE, manufactured by American Health Packaging. There are 163 FDA adverse event reports linking IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE to DRUG INEFFECTIVE. This represents approximately 4.3% of all 3,750 adverse event reports for this drug.
Patients taking IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is moderately reported among IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE users, representing a notable but not dominant share of adverse events.
In addition to drug ineffective, the following adverse reactions have been reported for IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 163 FDA reports for IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 4.3% of all adverse event reports for IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.